Metabolic and bariatric surgeries in individuals with obesity and BMI of 30-35 kg/m2: systematic review.
作者信息
Silvinato Antonio, Floriano Idevaldo, Bernardo Wanderley Marques
机构信息
Brazilian Medical Association, Evidence-Based Medicine - São Paulo (SP), Brazil.
Universidade de São Paulo, Faculty of Medicine - São Paulo (SP), Brazil.
出版信息
Rev Assoc Med Bras (1992). 2025 Jun 2;71(4):e2025D714. doi: 10.1590/1806-9282.2025D714. eCollection 2025.
Abstract
摘要
相似文献
1
Metabolic and bariatric surgeries in individuals with obesity and BMI of 30-35 kg/m2: systematic review.肥胖且体重指数为30 - 35kg/m²的个体进行代谢和减重手术：系统评价
Rev Assoc Med Bras (1992). 2025 Jun 2;71(4):e2025D714. doi: 10.1590/1806-9282.2025D714. eCollection 2025.
2
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益：一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
3
Bariatric surgery: an evidence-based analysis.减重手术：一项基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(1):1-148. Epub 2005 Jan 1.
4
Metabolic Bariatric surgery in People with Obesity aged ≥65 Years.65岁及以上肥胖人群的代谢性减肥手术
Eur J Intern Med. 2024 Dec;130:19-32. doi: 10.1016/j.ejim.2024.03.029. Epub 2024 Mar 30.
5
Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2.体重指数低于35kg/m²的2型糖尿病患者的减重/代谢手术治疗
Diabetes Care. 2016 Jun;39(6):924-33. doi: 10.2337/dc16-0350.
6
IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management.国际肥胖与代谢病外科联盟（IFSO）肥胖症内镜治疗委员会关于内镜下袖状胃成形术治疗肥胖症的循证回顾与立场声明。
Obes Surg. 2024 Dec;34(12):4318-4348. doi: 10.1007/s11695-024-07510-z. Epub 2024 Nov 1.
7
Cohort study on incidence of new-onset type 2 diabetes in patients after bariatric surgery and matched controls.队列研究：减重手术后患者与匹配对照者新发 2 型糖尿病的发病率。
Br J Surg. 2024 Apr 3;111(4). doi: 10.1093/bjs/znae105.
8
Are we operating too late? Mortality Analysis and Stochastic Simulation of Costs Associated with Bariatric Surgery: Reconsidering the BMI Threshold.我们手术是否做得太晚了？减重手术相关成本的死亡率分析与随机模拟：重新审视体重指数阈值。
Obes Surg. 2016 Jan;26(1):219-28. doi: 10.1007/s11695-015-1934-x.
9
[Interpretation for indications of metabolic and bariatric surgery released by ASMBS and IFSO in 2022].[美国代谢与减重外科学会（ASMBS）和国际肥胖与代谢病外科联盟（IFSO）2022年发布的代谢与减重手术适应证解读]
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Apr 25;26(4):385-388. doi: 10.3760/cma.j.cn441530-20221221-00534.
10
2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery.2022 年美国代谢与减重外科学会（ASMBS）和国际肥胖与代谢外科联合会（IFSO）代谢与减重手术适应证。
Obes Surg. 2023 Jan;33(1):3-14. doi: 10.1007/s11695-022-06332-1.
本文引用的文献
1
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2022 年美国糖尿病协会 (ADA) 和欧洲糖尿病研究协会 (EASD) 共识报告：2 型糖尿病患者高血糖管理。
Diabetes Care. 2022 Nov 1;45(11):2753-2786. doi: 10.2337/dci22-0034.
2
Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes.饮食与胃旁路手术对糖尿病代谢功能的影响。
N Engl J Med. 2020 Aug 20;383(8):721-732. doi: 10.1056/NEJMoa2003697.
3
Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity: A Randomized Clinical Trial.胃旁路手术与最佳药物治疗对 2 型糖尿病合并肥胖的早期慢性肾脏病患者的影响：一项随机临床试验。
JAMA Surg. 2020 Aug 1;155(8):e200420. doi: 10.1001/jamasurg.2020.0420. Epub 2020 Aug 19.
4
Long-term outcomes comparing metabolic surgery to no surgery in patients with type 2 diabetes and body mass index 30-35.比较代谢手术与无手术治疗 2 型糖尿病合并 BMI 30-35 患者的长期结局。
Surg Obes Relat Dis. 2020 Apr;16(4):503-508. doi: 10.1016/j.soard.2020.01.016. Epub 2020 Jan 23.
5
RoB 2: a revised tool for assessing risk of bias in randomised trials.《随机对照试验偏倚风险评估工具2：修订版》
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
6
PYY plays a key role in the resolution of diabetes following bariatric surgery in humans.PYY 在人类减肥手术后糖尿病的缓解中发挥关键作用。
EBioMedicine. 2019 Feb;40:67-76. doi: 10.1016/j.ebiom.2018.12.040. Epub 2019 Jan 11.
7
Health Effects of Overweight and Obesity in 195 Countries.195个国家超重和肥胖对健康的影响
N Engl J Med. 2017 Oct 12;377(15):1496-7. doi: 10.1056/NEJMc1710026.
8
National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m).Roux-en-Y胃旁路手术后2型糖尿病缓解的国家差异——糖尿病手术研究2年结果的亚组分析，比较台湾地区与轻度肥胖（BMI 30-35 kg/m²）的美国患者
Obes Surg. 2017 May;27(5):1189-1195. doi: 10.1007/s11695-016-2433-4.
9
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.代谢手术在 2 型糖尿病治疗方案中的作用：国际糖尿病组织联合声明。
Diabetes Care. 2016 Jun;39(6):861-77. doi: 10.2337/dc16-0236.
10
Three-year follow-up comparing metabolic surgery versus medical weight management in patients with type 2 diabetes and BMI 30-35. The role of sRAGE biomarker as predictor of satisfactory outcomes.对2型糖尿病且体重指数（BMI）为30 - 35的患者进行代谢手术与药物体重管理的三年随访。可溶性晚期糖基化终末产物受体（sRAGE）生物标志物作为满意结果预测指标的作用。
Surg Obes Relat Dis. 2016 Aug;12(7):1337-1341. doi: 10.1016/j.soard.2016.01.016. Epub 2016 Jan 21.
Zotero 插件